Pure Global

PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma - Trial NCT06322927

Access comprehensive clinical trial information for NCT06322927 through Pure Global AI's free database. This phase not specified trial is sponsored by The Christie NHS Foundation Trust and is currently Not yet recruiting. The study focuses on Multiple Myeloma. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06322927
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06322927
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma

Study Focus

Multiple Myeloma

Patient Interview

Observational

other

Sponsor & Location

The Christie NHS Foundation Trust

Manchester, United Kingdom

Timeline & Enrollment

N/A

Mar 31, 2024

Sep 30, 2024

15 participants

Primary Outcome

Patient Experience and Preference

Summary

This is a qualitative (interview) study to explore the experiences of people receiving
 treatment for MM and to understand what matters most to them when making treatment decisions.

ICD-10 Classifications

Multiple myeloma
Multiple myeloma and malignant plasma cell neoplasms
Other myeloid leukaemia
Myeloid leukaemia
Other myelodysplastic syndromes

Data Source

ClinicalTrials.gov

NCT06322927

Non-Device Trial